Table 1.
Baseline demographics of patients with SSc.
| Characteristics | SSc, n = 15 1 |
|---|---|
| Age | 53 (48, 60) |
| Gender | |
| female | 15 (100%) |
| SSc subtype | |
| diffuse cutaneous | 6 (40%) |
| limited cutaneous | 9 (60%) |
| Disease duration (years) | 4 (0.5, 9.0) |
| Disease duration (early ≤ 3 years; late >3 years) | |
| early | 7 (47%) |
| late | 8 (53%) |
| Calcinosis | 2 (13%) |
| Telangiectasis | 9 (60%) |
| Digital ulcers (previous, current, never) | |
| previous | 7 (47%) |
| current | 2 (13%) |
| never | 6 (40%) |
| ILD | 8 (53%) |
| Arrythmias requiring therapy | 4 (27%) |
| Conduction blocks | 2 (13%) |
| PAH requiring therapy | 1 (6.7%) |
| Esophagitis | 5 (33%) |
| ANA | |
| positive | 15 (100%) |
| anti-Scl-70 antibodies | |
| positive | 8 (53%) |
| anti-centromere antibodies | |
| positive | 5 (33%) |
1 n (%); median (IQR). SSc = systemic sclerosis; ILD = interstitial lung disease; PAH = pulmonary arterial hypertension; ANA = antinuclear antibodies.